secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2022-06-27T23:59:59+00:00
Accession:  0001104659-22-074485
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Hepion Pharma annual meeting: equity plan & say-on-pay fail; 3 directors face majority withhold votes
--------------------------------------------------------------------------------

- Proposal 3 (2022 Omnibus Equity Incentive Plan) failed: 11.0M for, 20.1M against.
- Proposal 5 (say-on-pay) failed: 9.2M for, 21.6M against.
- Directors Gary Jacob, John Brancaccio, and Timothy Block each received more withhold votes than for votes.
- Proposal 4 (authorized share increase) adjourned to July 22, 2022 due to insufficient votes.
- Proposal 2 (ratify BDO USA as auditor) passed with 31.1M for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000110465922074485/0001104659-22-074485-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000110465922074485/tm2219430d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-074485

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer